Email bulletin archive Archive December 2016 Experimental treatments for hepatitis B 8-week sofosbuvir/ledipasvir treatment course DAA treatment in HIV/HCV co-infection Adherence Use of generic drugs for treatment of hepatitis C Prequalified hepatitis C rapid test Is this your copy of the infohep news bulletin? November 2016 News from the 2016 AASLD Liver Meeting New pangenotypic combinations Hepatitis C genotype 3 Real world treatment performance matches the best clinical trial results Treatment scale-up and the continuum of care Liver cancer in people treated with direct-acting antivirals Hepatitis B treatment Generic hepatitis C drugs Is this your copy of the infohep news bulletin? October 2016 Over one million people treated for hepatitis C in low- and middle-income countries FDA hepatitis B reactivation warning, and hepatitis B testing for people taking hepatitis C treatment Hepatitis B elimination European action plan for the health sector response to viral hepatitis Reinfection risk Mortality risk after SVR in Scotland Shortening treatment Access to treatment Next month: news coverage of The Liver Meeting 2016 Is this your copy of the infohep news bulletin? September 2016 New European guidelines for treatment of hepatitis C HCV treatment for people who inject drugs Alcohol and liver damage in people with hepatitis C Reduced fatigue after hepatitis C cure HCV vaccine Access to sofosbuvir in Ukraine International Viral Hepatitis Elimination Meeting 2016 Is this your copy of the infohep news bulletin? August 2016 Hep-CORE study highlights gaps in European responses to viral hepatitis Zepatier receives EU marketing approval Risk factors for fibrosis progression Statins and progression of fibrosis in people with HIV/HCV co-infection Hepatitis B monitoring Is this your copy of the infohep news bulletin? July 2016 World Hepatitis Day: the launch of the NOhep movement Sofosbuvir/velpatasvir (Epclusa) approval in European Union and United States Viekirax treatment course for genotype 4 reduced in European Union US treatment guidelines updated Viral hepatitis worldwide Diabetes, cirrhosis and liver cancer Portal hypertension Is this your copy of the infohep news bulletin? June 2016 Access to hepatitis C treatment: France, Ireland and India Hepatitis C treatment rationing Global targets for the elimination of viral hepatitis Making hepatitis C diagnosis easier Is this your copy of the infohep news bulletin? May 2016 Governments commit to eliminating viral hepatitis by 2030 at World Health Assembly Two new DAA combinations set for approval in the European Union Hepatitis B treatment Hepatitis C burden of disease Access to hepatitis C treatment HIV and hepatitis C Experimental treatment for cirrhosis Head and neck cancers The 5th International Symposium on Hepatitis Care in Substance Users Is this your copy of the infohep news bulletin? April 2016 News from the 2016 International Liver Congress Infohep webinar recording Generic drugs for hepatitis C treatment New generic combination to be tested in clinical trials NOhep campaign Hepatitis C treatment highly effective in real-world settings Hepatitis C treatment in advanced liver disease Hepatitis C treatment for people whose first DAA regimen failed Hepatitis C genotype 3 treatment Reinfection and treatment in acute infection Pangenotypic treatment in people with HIV/HCV co-infection Is this your copy of the infohep news bulletin? March 2016 WHO guidelines update Counterfeit Harvoni in Europe Hepatitis B prevalence HIV and HCV co-infection Treatment of acute HCV infection Genotype 4 HCV and lymphoma Screening for hepatitis C Upcoming event at ILC 2016: Transforming HCV Care Together Is this your copy of the infohep news bulletin? February 2016 Daklinza label expanded in Europe Cholesterol and liver damage in women with hepatitis C Cryoglobulinemia and direct-acting antivirals CDC warning on dialysis Drug pricing controversy builds in the United States Online treatment access data collection Improving referral from primary care Anti-microRNAs: a new experimental treatment for hepatitis C World Hepatitis Alliance Webinars Is this your copy of the infohep news bulletin? January 2016 Cardiovascular disease and hepatitis C Parkinson’s disease Australia hepatitis C treatment funding Hepatitis testing contest New Merck combination Zepatier approved for hepatitis C treatment in the United States New hepatitis C drugs in development Hepatitis B treatment Is this your copy of the infohep news bulletin? 2022202120202019201820172016201520142013 Other pages in this section Latest news All the news Conference news Email bulletin archive